New pharmacological properties of Medicago sativa and Saponaria officinalis saponin-rich fractions addressed to Candida albicans

Journal of Medical Microbiology

Volumn 63, Issue PART 8, 2014, Pages 1076-1086

  Sadowska, Beata ^a   Budzyńska, Aleksandra ^a   Wieckowska Szakiel, Marzena ^a   Paszkiewicz, Małgorzata ^a   Stochmal, Anna ^b   Moniuszko Szajwaj, Barbara ^b   Kowalczyk, Mariusz ^b   Rózalska, Barbara ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b STATE RESEARCH INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; CELL LINE; CELL WALL; FIBROBLASTS; MEDICAGO SATIVA; MICE; OXIDATIVE STRESS; PLANT EXTRACTS; SAPONARIA; SAPONINS;

EID: 84905174090     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.075291-0     Document Type: Article

References (42)

1. Abid Ali Khan, M. M., Naqvi, T. S. & Naqvi, M. S. (2012). Identification of phytosaponis as novel biodynamic agents: an updated overview. Asian J Exp Biol Sci 3, 459-467.
2. Avato, P., Bucci, R., Tava, A., Vitali, C., Rosato, A., Bialy, Z. & Jurzysta, M. (2006). Antimicrobial activity of saponins from Medicago sp.: structure-activity relationship. Phytother Res 20, 454-457.
3. Balestrazzi, A., Agoni, V., Tava, A., Avato, P., Biazzi, E., Raimondi, E., Macovei, A. & Carbonera, D. (2011). Cell death induction and nitric oxide biosynthesis in white poplar (Populus alba) suspension cultures exposed to alfalfa saponins. Physiol Plant 141, 227-238.
4. Bhattacharyya, S., Gupta, P., Banerjee, G., Jain, A. & Singh, M. (2013). In-vitro inhibition of biofilm formation in Candida albicans and Candida tropicalis by heat stable compounds in culture filtrate of Aspergillus flavus. J Clin Diagn Res 7, 2167-2169.
5. Bink, A., Pellens, K., Cammue, B. P. A. & Thevissen, K. (2011). Antibiofilm strategies: how to eradicate Candida biofilms? Open Mycol J 5, 29-38.
6. Böttger, S. & Melzig, M. F. (2011). Triterpenoid saponins of the Caryophyllaceae and Illecebraceae family. Phytochem Lett 4, 59-68.
7. Budzyńska, A., Sadowska, B., Lipowczan, G., Maciag, A., Kalemba, D. & Róz alska, B. (2013). Activity of selected essential oils against Candida spp. strains. Evaluation of new aspects of their specific pharmacological properties, with special reference to Lemon Balm. Adv Microb 3, 317-325.
8. Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A. & Monk, B. C. (2009). Efflux-mediated antifungal drug resistance. Clin Microbiol Rev 22, 291-321.
9. Carelli, M., Biazzi, E., Panara, F., Tava, A., Scaramelli, L., Porceddu, A., Graham, N., Odoardi, M., Piano, E. & other authors (2011). Medicago truncatula CYP716A12 is a multifunctional oxidase involved in the biosynthesis of hemolytic saponins. Plant Cell 23, 3070-3081.
10. Chai, L. Y. A., Netea, M. G., Vonk, A. G. & Kullberg, B. J. (2009). Fungal strategies for overcoming host innate immune response. Med Mycol 47, 227-236.
11. Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T. & Ghannoum, M. A. (2001). Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183, 5385-5394.
12. Chevalier, M., Medioni, E. & Prêcheur, I. (2012). Inhibition of Candida albicans yeast-hyphal transition and biofilm formation by Solidago virgaurea water extracts. J Med Microbiol 61, 1016-1022.
13. CLSI (2009). Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Approved Guideline, 2nd edn, M44-A2.Wayne, PA: Clinical and Laboratory Standards Institute.
14. Coleman, J. J., Okoli, I., Tegos, G. P., Holson, E. B., Wagner, F. F., Hamblin, M. R. & Mylonakis, E. (2010). Characterization of plantderived saponin natural products against Candida albicans. ACS Chem Biol 5, 321-332.
15. Czaban, J., Modloch, J., Wroblewska, B., Szumacher-Strabel, M., Cieslak, A., Oleszek, W. & Stochmal, A. (2013). Effects of triterpenoid saponins of field scabious (Knautia arvensis L. Coult.) alfalfa, red clover and common soapwort on growth of Gaeumannomyces graminis var. tritici and Fusarium culmorum. Allelopathy J 32, 79-90.
16. D'Addabbo, T., Carbonara, T., Leonetti, P., Radicci, V., Tava, A. & Avato, P. (2011). Control of plant parasitic nematodes with active saponins and biomass from Medicago sativa. Phytochem Rev 10, 503-519.
17. Dongari-Bagtzoglou, A. (2008). Mucosal biofilms: challenges and future directions. Expert Rev Anti Infect Ther 6, 141-144.
18. Enjalbert, B., MacCallum, D. M., Odds, F. C. & Brown, A. J. P. (2007). Niche-specific activation of the oxidative stress response by the pathogenic fungus Candida albicans. Infect Immun 75, 2143-2151.
19. Francis, G., Kerem, Z., Makkar, H. P. S. & Becker, K. (2002). The biological action of saponins in animal systems: a review. Br J Nutr 88, 587-605.
20. Gauwerky, K., Borelli, C. & Korting, H. C. (2009). Targeting virulence: a new paradigm for antifungals. Drug Discov Today 14, 214-222.
21. Gropp, K., Schild, L., Schindler, S., Hube, B., Zipfel, P. F. & Skerka, Ch. (2009). The yeast Candida albicans evades human complement attack by secretion of aspartic proteases. Mol Immunol 47, 465-475.
22. Kabir, M. A. & Ahmad, Z. (2013). Candida infections and their prevention. ISRN Prev Med 2013, 763628.
23. Kabir, M. A., Hussain, M. A. & Ahmad, Z. (2012). Candida albicans: a model organisms for studying fungal pathogens. ISRN Microbiol 2012, 538694.
24. Liu, R. H. (2003). Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr 78 (Suppl), 517S-520S.
25. Mathé, L. & Van Dijck, P. (2013). Recent insights into Candida albicans biofilm resistance mechanisms. Curr Genet 59, 251-264.
26. Missall, T. A., Lodge, J. K. & McEwen, J. E. (2004). Mechanisms of resistance to oxidative and nitrosative stress: implications for fungal survival in mammalian hosts. Eukaryot Cell 3, 835-846.
27. Naicker, S. D. & Patel, M. (2013). Dodonaea viscosa var. angustifolia inhibits germ tube and biofilm formation by C. albicans. Evid Based Complement Alternat Med 2013, 261978.
28. Pemán, J., Cantón, E. & Espinel-Ingroff, A. (2009). Antifungal drug resistance mechanisms. Expert Rev Anti Infect Ther 7, 453-460.
29. Rajeshkumar, R. & Sundararaman, M. (2012). Emergence of Candida spp. and exploration of natural bioactive molecules for anticandidal therapy-status quo. Mycoses 55, e60-e73.
30. Sardi, J. C. O., Scorzoni, L., Bernardi, T., Fusco-Almeida, A. M. & Mendes Giannini, M. J. S. (2013). Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol 62, 10-24.
31. Seeram, N. P., Adams, L. S., Henning, S. M., Niu, Y., Zhang, Y., Nair, M. G. & Heber, D. (2005). In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem 16, 360-367.
32. Soustre, J., Rodier, M.-H., Imbert-Bouyer, S., Daniault, G. & Imbert, C. (2004). Caspofungin modulates in vitro adherence of Candida albicans to plastic coated with extracellular matrix proteins. J Antimicrob Chemother 53, 522-525.
33. Sparg, S. G., Light, M. E. & van Staden, J. (2004). Biological activities and distribution of plant saponins. J Ethnopharmacol 94, 219-243.
34. Sung, W. S. & Lee, D. G. (2008). In vitro candidacidal action of Korean red ginseng saponins against Candida albicans. Biol Pharm Bull 31, 139-142.
35. Tava, A. & Avato, P. (2006). Chemical and biological activity of triterpene saponins from Medicago species. Nat Prod Commun 1, 1159-1180.
36. te Welscher, Y. M., ten Napel, H. H., Balagué, M. M., Souza, C. M., Riezman, H., de Kruijff, B. & Breukink, E. (2008). Natamycin blocks fungal growth by binding specifically to ergosterol without permeabilizing the membrane. J Biol Chem 283, 6393-6401.
37. Timbekova, A. E., Isaev, M. I. & Abubakirov, N. K. (1996). Chemistry and biological activity of triterpenoid glycosides from Medicago sativa. Adv Exp Med Biol 405, 171-182.
38. Tlamçani, Z. & Er-rami, M. (2013). Fungal opportunist infection: common and emerging fungi in immunocompromised patients. J Immunol Tech Infect Dis 2, 2.
39. Tsuzuki, J. K., Svidzinski, T. I. E., Shinobu, C. S., Silva, L. F. A., Rodrigues-Filho, E., Cortez, D. A. G. & Ferreira, I. C. P. (2007). Antifungal activity of the extracts and saponins from Sapindus saponaria L. An Acad Bras Cienc 79, 577-583.
40. Udgirkar, R. F., Kadam, P. & Kale, N. (2013). Pharmacological importance of saponin glycoside: a review. Int J Med Pharm Sci Res Rev 1, 19-31.
41. Weng, A., Jenett-Siems, K., Schmieder, P., Bachran, D., Bachran, C., Görick, C., Thakur, M., Fuchs, H. & Melzig, M. F. (2010). A convenient method for saponin isolation in tumour therapy. J Chromatogr B Analyt Technol Biomed Life Sci 878, 713-718.
42. Wu, T., Wright, K., Hurst, S. F. & Morrison, C. J. (2000). Enhanced extracellular production of aspartyl proteinase, a virulence factor, by Candida albicans isolates following growth in subinhibitory concentrations of fluconazole. Antimicrob Agents Chemother 44, 1200-1208.